PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.45%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-3.98%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-17.81%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-20.34%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-18.30%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-18.29%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-18.29%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.35%
10Y CAGR of 4.35% while 3391.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
4.35%
5Y CAGR of 4.35% while 3391.T is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
-22.63%
Negative 3Y CAGR while 3391.T stands at 20.46%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 3Y OCF/share CAGR while 3391.T stands at 100.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
84.25%
10Y net income/share CAGR of 84.25% while 3391.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
84.25%
Net income/share CAGR of 84.25% while 3391.T is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
3.41%
Below 50% of 3391.T's 68.78%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
37.80%
Equity/share CAGR of 37.80% while 3391.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
37.80%
Equity/share CAGR of 37.80% while 3391.T is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
-6.14%
Negative 3Y equity/share growth while 3391.T is at 43.90%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.53%
Firm’s AR is declining while 3391.T shows 7.65%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
11.89%
Inventory growth well above 3391.T's 4.67%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.36%
Asset growth above 1.5x 3391.T's 3.52%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
5.37%
BV/share growth above 1.5x 3391.T's 3.43%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
307.59%
We have some new debt while 3391.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
2.63%
SG&A declining or stable vs. 3391.T's 5.39%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.